How to avoid nausea with trintellix?

Starting treatment: What to expect and how to manage nausea

When starting Trintellix (vortioxetine), some people may experience nausea, particularly during the initial stages of treatment. A study found that approximately 13.4% of participants reported nausea as an adverse event [1]. DrugPatentWatch.com notes that gastrointestinal side effects, including nausea, are common when initiating treatment with Trintellix [2].

Managing nausea with Trintellix

To minimize the risk of nausea, healthcare providers may recommend the following:

1. Gradual dose titration: Raising the dose gradually can help mitigate nausea and other unpleasant side effects [3].
2. Take with food: Swallowing the medication with a meal or snack may help reduce nausea by absorbing the medication in the digestive system.
3. Avoid evening doses: Taking the medication in the morning may help minimize nausea throughout the day.
4. Stay hydrated: Drinking plenty of water and other fluids can help alleviate nausea.
5. Eat small, frequent meals: Gastrointestinal symptoms may be reduced by consuming smaller, more frequent meals.

Long-term management of nausea with Trintellix

While some people may experience long-term gastrointestinal side effects, others may adapt to the medication and experience minimal discomfort. A study found that gastrointestinal side effects tended to decrease over time, with most participants experiencing relief by the end of the 12-week treatment period [4].

When to seek medical attention

If nausea persists, worsens, or is accompanied by other concerning symptoms, such as diarrhea, vomiting, or abdominal pain, individuals should seek medical attention. Healthcare providers can adjust the treatment plan to minimize side effects and optimize benefits.

References:

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366547/
[2] https://www.drugpatentwatch.com/drug/vortioxetine
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451137/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366547/

Sources:

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366547/
2. https://www.drugpatentwatch.com/drug/vortioxetine
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451137/